Ebola Vaccination
-
{
- All
- News
-
Congo Begins Ebola Vaccinations For Health Workers In The Epicenter Of The Outbreak
The rollout is targeting the Bunia and Mongbwalu zones in Ituri province, health authorities said Saturday. Both areas are among the hardest-hit by the virus.
-
Canada Approves Clinical Trials Of Moderna's Ebola Vaccine
Canada has authorized US pharmaceutical giant Moderna to begin clinical trials for a vaccine against the Bundibugyo strain of Ebola.
-
Oxford, Serum Institute Of India Launch Human Trials Of New Ebola Vaccine Against The Bundibugyo Strain
The Phase I clinical trial will take place in Oxford and involve 50 healthy volunteers between the ages of 18 and 55. The goal of this first-stage study is to check whether the vaccine is safe and whether it triggers the body's immune system to produce protection against the virus.
-
Ebola Trial Begins In Congo, Raising New Hope For Patients
Residents at the epicenter of Congo's Ebola outbreak are hoping that experimental treatments for Ebola will yield results. As researchers began a highly anticipated study in early July of two possible Ebola treatments in hopes of fighting the still-growing outbreak.
-
Trials Of 2 Ebola Treatments To Start In Congo Next Week: WHO
Trials of two separate potential treatments to fight the deadly Ebola outbreak in the Democratic Republic of Congo are expected to begin next week, according to the WHO.
-
India's Vaccine Support Emerges As Lifeline For Africa: Report
New Delhi, June 22 (IANS) The postponement of the India‑Africa Forum Summit IV -- originally scheduled for 28–31 May here -- over “emerging public health situation" from Bundibugyo Ebola outbreaks underscored India’s emerging role as a rapid vaccine manufacturer for Africa, a new report has said.
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
Ebola Vaccine Race Intensifies With Fund Surge, But Doctors Also Suggest Caution
There have been recent funding announcements which have created optimism among scientists and health officials. Several vaccine candidates are now moving through different stages of development.
-
'We Need To Act Now': Race To Develop Ebola Vaccine Heats Up
Several non-profit organisations announced Monday they are ramping up efforts to rapidly develop a vaccine for the rare strain of Ebola driving a deadly outbreak...
-
WHO Fast-Tracks Vaccines, Drugs Against Deadly Ebola Bundibugyo Strain
The Bundibugyo strain is one of several types of Ebola viruses known to infect humans. While Ebola is linked to severe bleeding, organ failure, and high death rates, different strains can behave differently.
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
Russia Claims Breakthrough Vaccine Against New Ebola Strain
Russia has announced the development of a vaccine targeting a new Ebola strain linked to the ongoing Bundibugyo outbreak in Congo and Uganda. Experts say the move could strengthen global outbreak preparedness, though clinical data is awaited
-
Russia Claims Breakthrough Vaccine Against New Ebola Strain
Russia has announced the development of a vaccine targeting a new Ebola strain linked to the ongoing Bundibugyo outbreak in Congo and Uganda. Experts say the move could strengthen global outbreak preparedness, though clinical data is awaited
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Congo Begins Ebola Vaccinations For Health Workers In The Epicenter Of The Outbreak
The rollout is targeting the Bunia and Mongbwalu zones in Ituri province, health authorities said Saturday. Both areas are among the hardest-hit by the virus.
-
Canada Approves Clinical Trials Of Moderna's Ebola Vaccine
Canada has authorized US pharmaceutical giant Moderna to begin clinical trials for a vaccine against the Bundibugyo strain of Ebola.
-
Oxford, Serum Institute Of India Launch Human Trials Of New Ebola Vaccine Against The Bundibugyo Strain
The Phase I clinical trial will take place in Oxford and involve 50 healthy volunteers between the ages of 18 and 55. The goal of this first-stage study is to check whether the vaccine is safe and whether it triggers the body's immune system to produce protection against the virus.
-
Ebola Trial Begins In Congo, Raising New Hope For Patients
Residents at the epicenter of Congo's Ebola outbreak are hoping that experimental treatments for Ebola will yield results. As researchers began a highly anticipated study in early July of two possible Ebola treatments in hopes of fighting the still-growing outbreak.
-
Trials Of 2 Ebola Treatments To Start In Congo Next Week: WHO
Trials of two separate potential treatments to fight the deadly Ebola outbreak in the Democratic Republic of Congo are expected to begin next week, according to the WHO.
-
India's Vaccine Support Emerges As Lifeline For Africa: Report
New Delhi, June 22 (IANS) The postponement of the India‑Africa Forum Summit IV -- originally scheduled for 28–31 May here -- over “emerging public health situation" from Bundibugyo Ebola outbreaks underscored India’s emerging role as a rapid vaccine manufacturer for Africa, a new report has said.
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
Ebola Vaccine Race Intensifies With Fund Surge, But Doctors Also Suggest Caution
There have been recent funding announcements which have created optimism among scientists and health officials. Several vaccine candidates are now moving through different stages of development.
-
'We Need To Act Now': Race To Develop Ebola Vaccine Heats Up
Several non-profit organisations announced Monday they are ramping up efforts to rapidly develop a vaccine for the rare strain of Ebola driving a deadly outbreak...
-
WHO Fast-Tracks Vaccines, Drugs Against Deadly Ebola Bundibugyo Strain
The Bundibugyo strain is one of several types of Ebola viruses known to infect humans. While Ebola is linked to severe bleeding, organ failure, and high death rates, different strains can behave differently.
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
Russia Claims Breakthrough Vaccine Against New Ebola Strain
Russia has announced the development of a vaccine targeting a new Ebola strain linked to the ongoing Bundibugyo outbreak in Congo and Uganda. Experts say the move could strengthen global outbreak preparedness, though clinical data is awaited
-
Russia Claims Breakthrough Vaccine Against New Ebola Strain
Russia has announced the development of a vaccine targeting a new Ebola strain linked to the ongoing Bundibugyo outbreak in Congo and Uganda. Experts say the move could strengthen global outbreak preparedness, though clinical data is awaited
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
